GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rigel Pharmaceuticals Inc (STU:RI2A) » Definitions » FCF Yield %

Rigel Pharmaceuticals (STU:RI2A) FCF Yield % : -4.08 (As of Jun. 16, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Rigel Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Rigel Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-6.3 Mil, and Market Cap is €155.7 Mil. Therefore, Rigel Pharmaceuticals's FCF Yield % for today is -4.08%.

The historical rank and industry rank for Rigel Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:RI2A' s FCF Yield % Range Over the Past 10 Years
Min: -56.78   Med: -16.27   Max: 2.01
Current: -4.08


During the past 13 years, the highest FCF Yield % of Rigel Pharmaceuticals was 2.01%. The lowest was -56.78%. And the median was -16.27%.

STU:RI2A's FCF Yield % is ranked better than
73.39% of 1552 companies
in the Biotechnology industry
Industry Median: -13.865 vs STU:RI2A: -4.08

Rigel Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was -17.44%.


Rigel Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Rigel Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rigel Pharmaceuticals FCF Yield % Chart

Rigel Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.44 -9.14 1.15 -31.90 -7.89

Rigel Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.38 10.38 -2.80 -9.49 -8.08

Competitive Comparison of Rigel Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Rigel Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rigel Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rigel Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Rigel Pharmaceuticals's FCF Yield % falls into.



Rigel Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Rigel Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-19.021 / 241.085054
=-7.89%

Rigel Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-4.739 * 4 / 234.517822
=-8.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rigel Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Rigel Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Rigel Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rigel Pharmaceuticals (STU:RI2A) Business Description

Traded in Other Exchanges
Address
611 Gateway Boulevard, Suite 900, South San Francisco, CA, USA, 94080
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Rigel Pharmaceuticals (STU:RI2A) Headlines

No Headlines